Literature DB >> 3925026

Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma.

R Fleischmajer, R Timpl, M Dziadek, M Lebwohl.   

Abstract

The distribution and nature of extracellular matrix proteins in neurofibroma tissue was studied by indirect immunofluorescence, immunoelectron microscopy, immunoblotting, and rotary shadowing. The most striking feature was an extensive network of basement membranes localized mainly around Schwann cells and small blood vessels. The major components, collagen IV, laminin, and nidogen, were mainly deposited in the lamina densa. Some laminin and nidogen could be extracted with 0.5 M NaCl and were shown by electrophoresis to have the characteristic chain and fragment patterns described previously for these proteins isolated from the mouse Engelbreth-Holm-Swarm (EHS) sarcoma. Fragments of collagen IV and collagen VI were solubilized by limited proteolytic digestion and identified after rotary shadowing. The more remote interstitial regions of the tumor contained cross-striated collagen fibrils which were composed of collagen III (diameter, 20-30 nm) or collagen I (diameter, 40-50 nm). Collagen fibrils thicker than 80 nm were not found. The interstitial regions also contained collagen VI as a fine filamentous network near cells and between collagen fibrils. Deposits of fibronectin were rather small and showed a scattered distribution. The data indicate that Schwann cells contribute considerably to matrix production in neurofibroma which may therefore be a suitable model for studying basement membranes of neuroectodermal origin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925026     DOI: 10.1111/1523-1747.ep12275341

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.

Authors:  T Nakamura; M Hara; T Kasuga
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

2.  Type VI collagen in experimental atherosclerosis.

Authors:  R Kittelberger; P F Davis; W E Stehbens
Journal:  Experientia       Date:  1990-03-15

3.  Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures.

Authors:  S Jaakkola; J Peltonen; V Riccardi; M L Chu; J Uitto
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Histopathological and immunohistochemical changes in neurosurgically resected epileptic foci.

Authors:  M J Kallioinen; E R Heikkinen; S Nyström
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

5.  Comparison of various basement membrane components in benign and malignant peripheral nerve tumours.

Authors:  S Haraida; A G Nerlich; K Bise; I Wiest; E Schleicher
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Type VI collagen microfibrils: evidence for a structural association with hyaluronan.

Authors:  C M Kielty; S P Whittaker; M E Grant; C A Shuttleworth
Journal:  J Cell Biol       Date:  1992-08       Impact factor: 10.539

7.  High resolution immunoelectron microscopic localization of functional domains of laminin, nidogen, and heparan sulfate proteoglycan in epithelial basement membrane of mouse cornea reveals different topological orientations.

Authors:  J C Schittny; R Timpl; J Engel
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

8.  Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.

Authors:  Jean-Philippe Brosseau; Adwait A Sathe; Yong Wang; Toan Nguyen; Donald A Glass; Chao Xing; Lu Q Le
Journal:  Acta Neuropathol Commun       Date:  2021-01-07       Impact factor: 7.801

9.  Ultrastructure of type VI collagen in human skin and cartilage suggests an anchoring function for this filamentous network.

Authors:  D R Keene; E Engvall; R W Glanville
Journal:  J Cell Biol       Date:  1988-11       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.